Showing 2841-2850 of 3223 results for "".
- Safer and More Effective Glaucoma Surgical Options Will Drive Surgery Device Treatment Penetration Over Next Five Yearshttps://modernod.com/news/safer-and-more-effective-glaucoma-surgical-options-will-drive-surgery-device-treatment-penetration-over-next-five-years/2478181/Expanding use of surgical devices in patients with all stages of glaucoma will increase the role of surgery in the glaucoma treatment paradigm over the next 5 years, according to a Market Scope report. There are four FDA-approved minimally invasive glaucoma surgery (MIGS) stents in the US:
- Patient Safety Advocate Group Calls for Congressional Action to Prevent Implementation of Contact Lens Rulehttps://modernod.com/news/patient-safety-advocate-group-calls-for-congressional-action-to-prevent-implementation-of-contact-lens-rule/2478178/The Health Care Alliance for Patient Safety (APS) released the following statement regarding the Federal Trade Commission’s (FTC) publication of the Contact Lens Rule in the Federal Register. The rule
- Sanofi Enters $3.7-Billion Deal to Buy Principia Biopharmahttps://modernod.com/news/sanofi-enters-3-7-billion-deal-to-buy-principia-biopharma/2478166/Sanofi announced Monday a definitive agreement to acquire all of Principia Biopharma’s outstanding stock for $100 per share in cash, representing an equity value of around $3.7 billion, boosting the French drugmaker’s core research areas of autoimmune and allergic diseases. The deal,
- Comparison of Mask Types Finds Key Differences in Filtrationhttps://modernod.com/news/comparison-of-mask-types-finds-key-differences-in-filtration/2478161/N95 masks that are well past their expiration date or have been used and re-sterilized are acceptable alternatives to standard new single-use N95 masks, new research indicates. But some masks start off with better filtration efficiency than others, according to a Medscape
- Nicox Partners Zerviate in the Gulf and Arab Marketshttps://modernod.com/news/nicox-partners-zerviate-in-the-gulf-and-arab-markets/2478152/Nicox SA announced the signature of an exclusive license agreement with Itrom Pharmaceutical Group for the registration and commercialization of Zerviate (cetirizine ophthalmic solution), 0.24% for the treatment of ocular itching associated with allergic conjunctivitis in Gulf and Arab markets. I
- VSY Biotechnology Launches Enova Glistening-Free Hydrophobic Acrylic IOLhttps://modernod.com/news/vsy-biotechnology-launches-enova-glistening-free-hydrophobic-acrylic-iol/2478147/VSY Biotechnology announces the launch of the Enova IOL. Enova is the first 100% glistening-free hydrophobic acrylic IOL that does not require pre-hydration or storage in saline solution, according to VSY Biotechnology. The unique composition of Enova material allows uniform hydration of s
- Serum Institute to Produce COVID-19 Vaccines From AstraZeneca, Novavaxhttps://modernod.com/news/serum-institute-to-produce-covid-19-vaccines-from-astrazeneca-novavax/2478139/The Serum Institute of India (SII) said it will produce coronavirus vaccines from AstraZeneca and Novavax, making them available for procurement, if they gain marketing approval, at a ceiling price of $3 per dose. SII noted that it will use funding from Gavi, The Vaccine Alliance and the Bill &am
- AstraZeneca Takes COVID-19 Vaccine to China With BioKangtai Deal for 200M-Dose Capacity by 2021https://modernod.com/news/astrazeneca-takes-covid-19-vaccine-to-china-with-biokangtai-deal-for-200m-dose-capacity-by-2021/2478134/Last week China was a notable missing element in AstraZeneca’s COVID-19 vaccine strategy, despite being the drugmaker’s second-largest market. That has changed, according to a FiercePharma
- Researchers Discover Predictor of Laser Treatment Success in Patients With Glaucomahttps://modernod.com/news/researchers-discover-predictor-of-laser-treatment-success-in-patients-with-glaucoma/2478127/A new study from the University of Missouri School of Medicine and MU Health Care provides insight into which patients might benefit most from selective laser trabeculoplasty (SLT), which relieves pressure by using a laser to alter the eye tissue, resulting in better fluid drainage. “There
- American College of Surgeons Strongly Opposes Proposed Medicare Physician Fee Schedulehttps://modernod.com/news/american-college-of-surgeons-strongly-opposes-proposed-medicare-physician-fee-schedule/2478117/The American College of Surgeons (ACS) stated that it strongly opposes the Medicare Physician Fee Schedule proposed rule released by the Centers for Medicare & Medicaid Services (CMS) for 2021, which hurts our health care system and surgical care at the expense of patients. Although the propo